The current, generally accepted model of DC-SIGN-mediated HIV-1 infection utilises DC-SIGN+ cells, such as DCs, to transport virions from sites of HIV-1 exposure—at the mucosal membranes or bloodstream—to CD4+ T-cell targets in the lymphoid tissues (reviewed in [182]). The gene discussed is CD209; the disease is HIV-1 infection.